US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,476.68

-3.3748-0.23%

Number of Gainers:4

Number of Losers:15

Number of Flat:1

PE:- -

High:1,493.87

Open:1,479.95

Low:1,472.49

Close:1,480.06

Loading ...

Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate Ocu410st for Stargardt Disease

THOMSON REUTERS

Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease

Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds

Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant

Novavax Shares up 1.6% Premarket After Narrower Q4 Loss

THOMSON REUTERS

Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines

Novavax Outlook 2025 Adj Licensing, Royalties & Other REV $300 Mln to $350 Mln

THOMSON REUTERS

Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

THOMSON REUTERS

Novavax: Potential Executive Actions Limiting U.S. FDA Oversight, Routine Reviews May Negatively Impact Business - Filing

THOMSON REUTERS

Novavax: Face Uncertainty Regarding Potential for Changes in Regulatory Environment Following Change in Presidential Administration in Jan

THOMSON REUTERS

Global Business Travel reports Q4 revenue $591M, consensus $589.16M

Deutsche Pfandbriefbank (0R9K) Receives a Buy from Warburg Research

Market Chatter: Trump Administration Reviewing Moderna Bird Flu Vaccine Contract Amid Spending Scrutiny

MT Newswires Live

BUZZ-Moderna falls after report Trump administration weighs pulling funding for its bird flu vaccine

Moderna Shares Down 4.3% Premarket After Report Trump Administration Weighs Pulling Funding for Co's Bird Flu Vaccine

THOMSON REUTERS

Trump Team May Block Moderna’s (MRNA) Bird Flu Vaccine Funding

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1476.6809,"timestamp":1741636799999,"preClose":1480.0557,"halted":0,"volume":122705204,"delay":0,"changeRate":-0.00228,"change":-3.374756,"pbRate":4.037358,"amount":7785386246.180461,"amplitude":0.01444,"prevYearClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"turnoverRate":0.007934,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1493.8654,"amplitude":0.01444,"preClose":1480.0557,"low":1472.4934,"pbRate":"4.037358","latestPrice":1476.6809,"volume":122705204,"delay":0,"open":1479.9548,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"sixtyDayClose":1302.6017,"secType":"PLATE","market":"US","turnoverRate":0.007934,"peRate":31.999995,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"timestamp":1741636799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":15,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514807148","title":"Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate Ocu410st for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2514807148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514807148?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:46","pubTimestamp":1740664010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA6SCFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":0},{"id":"2514991800","title":"Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2514991800","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514991800?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:46","pubTimestamp":1740663960,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Feb.  27, 2025  (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced thata","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033879/0/en/Ocugen-Inc-Announces-FDA-Alignment-on-Phase-2-3-Pivotal-Confirmatory-Clinical-Trial-for-Modifier-Gene-Therapy-Candidate-OCU410ST-for-Stargardt-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":1},{"id":"2514880823","title":"Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2514880823","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514880823?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:38","pubTimestamp":1740663513,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson  stands against the other best vaccine stocks to buy now.What Will Trump’s Tariffs Mean for the Pharma Industry?On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay on their implementation. When asked about the postponed tariffs at a White House press conference, President Trump said:. “The tariffs are going forward on time, on schedule.”He claimed that foreign nations have been taking advantage of the US in “just about everything,” reiterating his plans to impose “reciprocal tariffs.”“So the tariffs will go forward, yes, and we’re going to make up a lot of territory,” Trump said.We recently discussed what Trump’s tariffs could mean for the healthcare","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-one-best-133833643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002141913.USD","LU1057294990.SGD","LU2112291526.USD","LU2129689514.USD","LU1244550221.USD","BK4504","LU0912757837.SGD","LU1032955483.USD","LU0320765646.SGD","LU2347655156.SGD","LU1221951046.USD","IE00BDGV0183.EUR","LU0058720904.USD","LU0640476718.USD","JNJ","LU1585245621.USD","IE00B3PB1722.GBP","LU1929549753.HKD","BK4568","LU0882574055.USD","IE00BSNM7G36.USD","BK4559","LU1023059063.AUD","LU0114720955.EUR","LU0345769128.USD","LU1066051811.HKD","LU1267930813.SGD","LU2129689605.HKD","IE0002270589.USD","BK4550","LU2133065610.SGD","LU0345769631.USD","BK4534","LU1506573853.SGD","LU2430703251.USD","LU0795875086.SGD","LU0234572021.USD","LU2089984988.USD","LU0122379950.USD","LU1261432733.SGD","IE00BJT1NW94.SGD","BK4007","LU0098860793.USD","LU2592432038.USD","LU0289739699.SGD","BK4588","IE00BJJMRZ35.SGD","LU1059921491.USD","LU2468319806.SGD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2514802876","title":"Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2514802876","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514802876?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:18","pubTimestamp":1740662315,"startTime":"0","endTime":"0","summary":"On an adjusted basis, the company reported a profit of 54 cents per share, compared with analysts' estimates of 57 cents per share, according to data compiled by LSEG.It reported a revenue of $3.52 billion for the fourth quarter, compared with analysts' average estimate of $3.61 billion.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","IE0002270589.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4534","LU0122379950.USD","LU1894683264.USD","BK4592","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","LU0868494617.USD","LU1066053197.SGD","SG9999013999.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0321505439.SGD","VTRS","SG9999001176.SGD","BK4007","IE00B19Z3581.USD","LU0306806265.USD","LU1066051498.USD","LU1883839398.USD","BK4585","LU2087621335.USD","LU0170899867.USD","LU0306807586.USD","LU0225284248.USD","SG9999002232.USD","BK4581","IE00B19Z3B42.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","BK4568","LU0058720904.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4583","LU0225771236.USD","LU0456855351.SGD","BK4533","LU1839511570.USD","BK4599","LU0985481810.HKD","LU0234572021.USD"],"gpt_icon":1},{"id":"2514547804","title":"Novavax Shares up 1.6% Premarket After Narrower Q4 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514547804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514547804?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:05","pubTimestamp":1740661530,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI17R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVAX","BK4585","BK4568","BK4547","BK4588"],"gpt_icon":0},{"id":"2514804835","title":"Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804835","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804835?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:02","pubTimestamp":1740661356,"startTime":"0","endTime":"0","summary":"Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines Feb 27 (Reuters) - Novavax's NVAX.O fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1883839398.USD","SG9999013999.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU0306807586.USD","BK4139","BK4551","LU0321505868.SGD","BK4592","BK4533","BK4548","BK4581","LU0058720904.USD","LU0225284248.USD","LU0170899867.USD","LU0306806265.USD","IE000M9KFDE8.USD","BK4568","BK4547","LU1023059063.AUD","SG9999001176.USD","LU1894683348.USD","SG9999001176.SGD","BK4550","IE00B19Z3B42.SGD","NVAX","BK4585","LU0321505439.SGD","LU0985481810.HKD","BK4534","SGXZ57979304.SGD","LU0234572021.USD","BK4599","LU1066051498.USD","LU0122379950.USD","IE00BLSP4239.USD","SG9999003800.SGD","BK4501","BK4532","BK4007","IE00BBT3K403.USD","LU0225771236.USD","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1066053197.SGD","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2514801018","title":"Novavax Outlook 2025 Adj Licensing, Royalties & Other REV $300 Mln to $350 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514801018?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nP8N3K10TX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","NVAX","BK4139","BK4547","BK4585","BK4588"],"gpt_icon":0},{"id":"2514480106","title":"Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2514480106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514480106?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4585","BK4547","BK4588","BK4139","BK4568"],"gpt_icon":0},{"id":"2514801634","title":"Novavax: Potential Executive Actions Limiting U.S. FDA Oversight, Routine Reviews May Negatively Impact Business - Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514801634?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:51","pubTimestamp":1740660671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI13N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4585","BK4547","BK4588","BK4139","BK4568"],"gpt_icon":0},{"id":"2514780157","title":"Novavax: Face Uncertainty Regarding Potential for Changes in Regulatory Environment Following Change in Presidential Administration in Jan","url":"https://stock-news.laohu8.com/highlight/detail?id=2514780157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514780157?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:51","pubTimestamp":1740660671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI13N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4139","BK4547","BK4588","BK4585","BK4568"],"gpt_icon":0},{"id":"2514801570","title":"Global Business Travel reports Q4 revenue $591M, consensus $589.16M","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801570","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514801570?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:50","pubTimestamp":1740660609,"startTime":"0","endTime":"0","summary":"Reports Q4 total transaction value $6.9B. Paul Abbott, Amex GBT’s CEO, stated: “We delivered on our financial targets for 2024 with a strong finish...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q4-revenue-591m-consensus-589-16m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q4-revenue-591m-consensus-589-16m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1721429741.USD","LU2089984988.USD","LU0868494617.USD","BK4566","IE0002141913.USD","LU2133065610.SGD","LU2237957902.USD","SG9999002232.USD","BK4581","BK4504","LU2112291526.USD","IE00BJT1NW94.SGD","BK4585","LU2237957811.SGD","IE00BFTCPJ56.SGD","LU1989763427.SGD","BK4568","IE0009355771.USD","BK4082","LU2468319806.SGD","LU1914381329.SGD","LU1721429402.USD","ABT","SG9999002224.SGD","LU1691799644.USD","BK4588","BK4592","LU1061106388.HKD","LU0170899867.USD","LU0234572021.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SGXZ23171101.USD","LU0266013472.USD","LU1023059063.AUD","LU1989763690.USD","SG9999004303.SGD","LU0122379950.USD","LU1057294990.SGD","BK4533"],"gpt_icon":0},{"id":"2514805792","title":"Deutsche Pfandbriefbank (0R9K) Receives a Buy from Warburg Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514805792?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:08","pubTimestamp":1740658101,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Plaesier from Warburg Research maintained a Buy rating on Deutsche Pfandbriefbank (0R9K – Research Report), wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-pfandbriefbank-0r9k-receives-a-buy-from-warburg-research-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-pfandbriefbank-0r9k-receives-a-buy-from-warburg-research-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4588","BK4195","BNTX","BK4229","BK4551","BK4585","BK4548","BK4139","BK4568","PBBGF"],"gpt_icon":0},{"id":"2514872162","title":"Market Chatter: Trump Administration Reviewing Moderna Bird Flu Vaccine Contract Amid Spending Scrutiny","url":"https://stock-news.laohu8.com/highlight/detail?id=2514872162","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514872162?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:53","pubTimestamp":1740653637,"startTime":"0","endTime":"0","summary":"Moderna  is facing a review of its $590 million contract for a bird flu vaccine that was awarded at the tail end of the Biden administration, Bloomberg News reported Thursday, citing unnamed people familiar with the matter.The review is part of a broader effort by the government to evaluate spending on mRNA-based vaccines, a technology widely used during the COVID-19 pandemic, according to the news outlet.The contract was reportedly issued during a severe bird flu outbreak that has affected poultry and livestock across the US, raising concerns about the virus' potential to spread to humans.A spokesperson for the Department of Health and Human Services said to Bloomberg the review is necessary due to what it described as inadequate oversight during the Biden administration.As sales of its Covid vaccine decline, Moderna has been looking for new revenue opportunities, with the bird flu contract seen as a significant part of its pipeline, Bloomberg quoted the sources as saying.Both Moderna","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4532","BK4501","BK4533","BK4534","BK4551","BK4585","MRNA","BK4139","BK4548","BK4568"],"gpt_icon":1},{"id":"2514874346","title":"BUZZ-Moderna falls after report Trump administration weighs pulling funding for its bird flu vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874346","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514874346?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:32","pubTimestamp":1740652362,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna falls after report Trump administration weighs pulling funding for its bird flu vaccine** Shares of Moderna MRNA.O fall 3.28% to $32.48 premarket** U.S. health officials are reevaluating a $590 million contract that was awarded to co for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources** The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna's COVID vaccine, the report added** The U.S. government awarded MRNA $590 million in January to advance the development of its bird flu vaccine** Shares have fallen nearly 65% in the last 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI0VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4501","BK4588","BK4548","BK4139","BK4551","BK4568","BK4534","MRNA","BK4533","BK4585"],"gpt_icon":1},{"id":"2514695820","title":"Moderna Shares Down 4.3% Premarket After Report Trump Administration Weighs Pulling Funding for Co's Bird Flu Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514695820","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514695820?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:04","pubTimestamp":1740647041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI0Q5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","MRNA","BK4532","BK4588","BK4585","BK4551","BK4548","BK4501","BK4533","BK4139","BK4568"],"gpt_icon":0},{"id":"2514829729","title":"Trump Team May Block Moderna’s (MRNA) Bird Flu Vaccine Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2514829729","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514829729?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:54","pubTimestamp":1740642870,"startTime":"0","endTime":"0","summary":"American pharmaceutical company Moderna ($MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is considering blocking f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/trump-team-may-block-modernas-mrna-bird-flu-vaccine-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/trump-team-may-block-modernas-mrna-bird-flu-vaccine-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4533","BK4120","BK4501","BK4532","BK4588","BK4534","TISI","BK4568","BK4551","MRNA","BK4548","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":19,"pageCount":16,"totalSize":302}]}}